<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-75370</identifier>
<setSpec>1130-1406</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Profile of antifungal susceptibility of species of Candida isolated from hemocultures in a university hospital, Maracaibo, Venezuela</dc:title>
<dc:description xml:lang="en">The aim of this study was to determine the in vitro susceptibility of amphotericin B, fluconazole and itraconazole, to several Candida spp recovered from blood cultures on hospitalized patients at the University Hospital of Maracaibo, Venezuela. The determination of the antifungal susceptibility was carried out according to the microdilution method in broth developed by The European Committee for Antimicrobial Susceptibility Testing (EUCAST). The profile of susceptibility of the 74 isolates showed that all the studied species were susceptible to amphotericin B, and 97.2% and 89.2% to fluconazole and itraconazole, respectively(AU)</dc:description>
<dc:creator>Milagros Calvo, B</dc:creator>
<dc:creator>Beltrán-Luengo, H</dc:creator>
<dc:creator>Arcaya, N. M</dc:creator>
<dc:creator>Pineda, M. R</dc:creator>
<dc:creator>Mesa, L. M</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El objetivo de este estudio fue determinar la sensibilidad in vitro a antfotericina B, fluconazol e itraconazol, de aislamientos de Candida, obtenidos de pacientes atendidos en el Servicio Autónomo Hospital Universitario de Maracaibo, Venezuela. La determinación de la sensibilidad a los antifúngicos se realizó según el método de dilución en caldo desarrollado por el European Comité for Antimicrobial Susceptibility Testing (EUCAST). El perfil de sensibilidad de 74 aislamientos mostró que todos fueron sensibles a anfotericina B, y el 97,2% y 89,2% lo fueron a fluconazol e itraconazol, respectivamente(AU)</dc:description>
<dc:source>Rev Iberoam Micol;23(2): 97-100, jun. 2006. tab</dc:source>
<dc:identifier>ibc-75370</dc:identifier>
<dc:title xml:lang="es">Perfil de sensibilidad antifúngica de especies de Candida aisladas de hemocultivos en un Hospital Universitario, Maracaibo, Venezuela</dc:title>
<dc:subject>^d27953^s22078</dc:subject>
<dc:subject>^d24654^s22078</dc:subject>
<dc:subject>^d943^s22078</dc:subject>
<dc:subject>^d15091^s22080</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d30095^s22080</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d24244</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d22780</dc:subject>
<dc:subject>^d31378^s22078</dc:subject>
<dc:subject>^d2209^s22046</dc:subject>
<dc:subject>^d2207^s22021</dc:subject>
<dc:subject>^d2207^s22001</dc:subject>
<dc:subject>^d30095^s22046</dc:subject>
<dc:subject>^d36324</dc:subject>
<dc:subject>^d2209^s22080</dc:subject>
<dc:type>article</dc:type>
<dc:date>200606</dc:date>
</metadata>
</record>
</ibecs-document>
